Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Our AI ranks Lifeloc Technologies, Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Lifeloc Technologies, Inc is a small-cap company with a market capitalization of $11M. It ranks number 23 by market capitalization among the 25 Laboratory Analytical Instruments issuers in our coverage with a current forecast.
For LCTC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -6.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -6.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, LCTC included.
Follow LCTC free90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Laboratory Analytical Instruments peers listed below that report each metric.
| Metric | LCTC | Rank |
|---|---|---|
| Market Cap | $11M | 23/25 |
| P/B Ratio | 2.88x | 9/23 |
| EPS | $-0.81 | – |
| Book Value/Share | $1.39 | – |
| Revenue/Share | $3.37 | – |
| FCF/Share | $-0.30 | – |
| Metric | LCTC | Rank |
|---|---|---|
| ROE | -54.3% | 16/20 |
| ROA | -29.3% | 14/20 |
| ROIC | -13.4% | 12/20 |
| Gross Margin | 42.0% | 15/19 |
| Operating Margin | -8.7% | 10/21 |
| Net Margin | -22.3% | 9/19 |
| EBT Margin | -8.4% | 10/22 |
| Tax Rate | -149.5% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
| Metric | LCTC | Rank |
|---|---|---|
| Current Ratio | 4.35x | 11/25 |
| Quick Ratio | 1.76x | 14/24 |
| D/E Ratio | 0.85x | 8/24 |
| Financial Leverage | 1.85x | 8/23 |
| Interest Coverage | -3.7x | 9/21 |
| Working Capital | $4M | 23/25 |
| Metric | LCTC | Rank |
|---|---|---|
| Operating Cash Flow | -$370K | 14/24 |
| Free Cash Flow | -$820K | 11/20 |
| Capital Spending | -$450K | 4/20 |
| FCF/Sales | -8.8% | 13/19 |
| CapEx/Sales | 4.8% | 4/19 |
| Metric | LCTC | Rank |
|---|---|---|
| Asset Turnover | 1.31x | 1/20 |
| Receivables Turnover | 11.2x | 3/19 |
| Inventory Turnover | 1.9x | 10/19 |
| Fixed Assets Turnover | 4.2x | 15/21 |
| Days Sales Outstanding | 33 days | 17/19 |
| Days Inventory | 193 days | 10/19 |
| Payables Period | 34 days | 16/18 |
| Cash Conversion Cycle | 191 days | 9/17 |
| Metric | LCTC | Rank |
|---|---|---|
| Total Revenue | $9M | 19/21 |
| Operating Income | -$800K | 7/21 |
| Net Income | -$2M | 8/21 |
| R&D Expense | $2M | 21/21 |
| Cost of Goods Sold | $5M | 17/19 |
| Metric | LCTC | Rank |
|---|---|---|
| Shares Outstanding | 3M | – |
| Total Current Assets | $5M | 67.5% of assets |
| Cash & Short-term Investments | $910K | 12.8% of assets |
| Accounts Receivable | $830K | 11.7% of assets |
| Inventory | $3M | 40.1% of assets |
| Total Liabilities | $3M | 46.0% of assets |
| Short-term Debt | $600K | 8.5% of assets |
Companies classified under the same SEC industry code as Lifeloc Technologies, Inc (Laboratory Analytical Instruments): 25 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| LCTC Lifeloc Technologies, Inc | ▲ | $11M |
| A Agilent Technologies, Inc. | ▼ | $48.75B |
| WAT Waters Corp /De/ | ▶ | $42.93B |
| ILMN Illumina, Inc. | ▲ | $39.64B |
| MTD Mettler Toledo International Inc/ | ▼ | $32.51B |
| RVTY Revvity, Inc. | ▶ | $17.03B |
| AVTR Avantor, Inc. | ▼ | $11.19B |
| BIO Bio-Rad Laboratories, Inc. | ▼ | $9.46B |
| TXG 10x Genomics, Inc. | ▲ | $9.10B |
| BRKR Bruker Corp | ▲ | $8.35B |
| ALMR Alamar Biosciences, Inc. | ▲ | $1.75B |
| CTKB Cytek Biosciences, Inc. | ▲ | $682M |
| PACB Pacific Biosciences Of California, Inc. | ▲ | $538M |
| MASS 908 Devices Inc. | ▲ | $465M |
| NAUT Nautilus Biotechnology, Inc. | ▲ | $262M |
| EYPT Eyepoint, Inc. | ▲ | $258M |
| BFNH Bioforce Nanosciences Holdings, Inc. | ▼ | $235M |
| QTRX Quanterix Corp | ▲ | $136M |
| SEER Seer, Inc. | ▲ | $113M |
| RPID Rapid Micro Biosystems, Inc. | ▲ | $42M |
| PRPO Precipio, Inc. | ▶ | $38M |
| HBIO Harvard Bioscience Inc | ▼ | $38M |
| BNGO Bionano Genomics, Inc. | ▲ | $15M |
| ASTC Astrotech Corp | ▶ | $10M |
| SCND Scientific Industries Inc | ▶ | $8M |
WHEAT RIDGE, CO / ACCESSWIRE / July 26, 2024 / Lifeloc Technologies, Inc. (OTC PINK:LCTC) (the "Company"), a global leader in the development and manufacturing of breath alcohol testing devices, has ...
Lifeloc Technologies, Inc. (OTC PINK:LCTC), a leading provider of portable breath alcohol testing devices and related solutions, today announced the successful closing of a $750,000 financing ...
WHEAT RIDGE, CO / ACCESS Newswire / August 25, 2025 / Lifeloc Technologies, Inc. (OTCID:LCTC), a U.S. leader in portable alcohol and drug testing solutions, unveiled its new SpinDetect™ Centrifugal ...
Our AI ranks Lifeloc Technologies, Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For LCTC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -6.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -6.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Lifeloc Technologies, Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
25 issuers in our coverage, LCTC included, share the SEC industry code Laboratory Analytical Instruments. The largest are: Agilent Technologies, Inc. (A), Waters Corp /De/ (WAT), Illumina, Inc. (ILMN), Mettler Toledo International Inc/ (MTD), Revvity, Inc. (RVTY), Avantor, Inc. (AVTR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.